Evidence map›Paper›PMID 34112868›Full record

ArticleScientific reports2021

Mechanistic insights into TNFR1/MADD death domains in Alzheimer's disease through conformational molecular dynamic analysis.

Mubashir Hassan, Sara Zahid, Hany Alashwal, Andrzej Kloczkowski, Ahmed A Moustafa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Tip60's Novel RNA-Binding Function Modulates Alternative Splicing of Pre-mRNA Targets Implicated in Alzheimer's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 5 countries.

Mubashir HassanInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. mubashirhassan_gcul@yahoo.com.
Sara ZahidInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
Hany AlashwalCollege of Information Technology, United Arab, Emirates University, Al-Ain, 15551, UAE. halashwal@uaeu.ac.ae.
Andrzej KloczkowskiBattelle Center for Mathematical Medicine, Nationwide Children's Hospital, Columbus, OH, 43205, USA.
Ahmed A MoustafaDepartment of Human Anatomy and Physiology, the Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.
University of Lahore · PKBattelle · USUnited Arab Emirates University · AEUniversity of Johannesburg · ZA

Funding

Protein Sequence MatchingR01GM127701 · NIGMS · IOWA STATE UNIVERSITY · PI JERNIGAN, ROBERT L, KLOCZKOWSKI, ANDRZEJ · 2018 to 2021
$1.4M
NIGMS NIH HHS R01 GM127701
6 · The paper itself

Abstract

Proteins are tiny players involved in the activation and deactivation of multiple signaling cascades through interactions in cells. The TNFR1 and MADD interact with each other and mediate downstream protein signaling pathways which cause neuronal cell death and Alzheimer's disease. In the current study, a molecular docking approach was employed to explore the interactive behavior of TNFR1 and MADD proteins and their role in the activation of downstream signaling pathways. The computational sequential and structural conformational results revealed that Asp400, Arg58, Arg59 were common residues of TNFR1 and MADD which are involved in the activation of downstream signaling pathways. Aspartic acid in negatively charged residues is involved in the biosynthesis of protein. However, arginine is a positively charged residue with the potential to interact with oppositely charged amino acids. Furthermore, our molecular dynamic simulation results also ensured the stability of the backbone of TNFR1 and MADD death domains (DDs) in binding interactions. This DDs interaction mediates some conformational changes in TNFR1 which leads to the activation of mediators proteins in the cellular signaling pathways. Taken together, a better understanding of TNFR1 and MADD receptors and their activated signaling cascade may help treat Alzheimer's disease. The death domains of TNFR1 and MADD could be used as a novel pharmacological target for the treatment of Alzheimer's disease by inhibiting the MAPK pathway.

Indexed as

Molecular Docking SimulationMolecular Dynamics SimulationProtein ConformationProtein Interaction Domains and MotifsAmino Acid SequenceBinding SitesDeath Domain Receptor Signaling Adaptor ProteinsGuanine Nucleotide Exchange FactorsHumansModels, BiologicalProtein BindingReceptors, Tumor Necrosis Factor, Type ISignal TransductionStructure-Activity RelationshipDeath Domain Receptor Signaling Adaptor ProteinsGuanine Nucleotide Exchange FactorsMADD protein, humanReceptors, Tumor Necrosis Factor, Type ITNFRSF1A protein, human

Identifiers

PMID34112868
PMCPMC8192743
OpenAlexW3168186887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.